Search

West Pharmaceutical Services Inc

Slēgts

SektorsVeselības aprūpe

353.57 2.25

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

343.43

Max

349.43

Galvenie mērījumi

By Trading Economics

Ienākumi

15M

154M

Pārdošana

27M

872M

P/E

Sektora vidējais

43.474

56.597

EPS

2.37

Dividenžu ienesīgums

0.25

Peļņas marža

17.654

Darbinieki

10,800

EBITDA

-39M

179M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+17.66% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

0.25%

2.18%

Nākamie ieņēmumi

2026. g. 22. okt.

Nākamais dividenžu datums

2026. g. 18. nov.

Nākamais Ex dividenžu datums

2026. g. 11. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-965M

24B

Iepriekšējā atvēršanas cena

351.32

Iepriekšējā slēgšanas cena

353.57

Ziņu noskaņojums

By Acuity

100%

0%

320 / 339 Rangs Healthcare

West Pharmaceutical Services Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 11. sept. 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

2026. g. 10. sept. 20:51 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours amid challenging broader market conditions and declining existing home sales for August.

2026. g. 9. sept. 20:07 UTC

West Pharmaceutical Services Inc. trades roughly flat amid a broader market trend, remaining near the lower end of its one-month range.

2026. g. 8. sept. 23:26 UTC

West Pharmaceutical Services Inc. shares are higher in after-market trading, showing modest gains since Tuesday's close despite no specific news to explain the movement.

2026. g. 4. sept. 19:36 UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

2026. g. 3. sept. 22:01 UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2026. g. 2. sept. 23:51 UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

2026. g. 1. sept. 23:51 UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

2026. g. 31. aug. 20:07 UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

2026. g. 28. aug. 23:11 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

2026. g. 27. aug. 23:02 UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

2026. g. 26. aug. 19:26 UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

2026. g. 25. aug. 23:26 UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

2026. g. 24. aug. 19:51 UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

2026. g. 21. aug. 23:01 UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

2026. g. 20. aug. 20:06 UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

2026. g. 19. aug. 20:06 UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

2026. g. 18. aug. 19:36 UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

2026. g. 17. aug. 22:55 UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

2026. g. 14. aug. 23:01 UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

2026. g. 13. aug. 23:36 UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

2026. g. 12. aug. 19:36 UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

2026. g. 11. aug. 19:26 UTC

West Pharmaceutical Services Inc is trading higher today, reflecting a gain since Monday. Market participants are watching upcoming U.S. inflation reports closely.

2026. g. 10. aug. 23:46 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a level near the upper end of their one-month range. No specific news was identified.

2026. g. 7. aug. 19:46 UTC

West Pharmaceutical Services Inc is trading higher during Friday's session, reflecting market strength. Shares remain above their 20-day moving average despite an earlier pullback.

2026. g. 6. aug. 20:51 UTC

West Pharmaceutical Services Inc. is roughly flat in after-market hours amid broader market declines and ahead of the upcoming non-farm payrolls report.

2026. g. 5. aug. 19:56 UTC

West Pharmaceutical Services shares are trading higher amid broader market gains, influenced by recent declines in oil prices and potential supply resolution.

2026. g. 4. aug. 20:51 UTC

West Pharmaceutical Services shares declined in after-hours trading, shifting downward despite an initial gain. No specific company news was identified for the movement.

2026. g. 3. aug. 19:46 UTC

News

Citigroup raised its price target on West Pharmaceutical Services to $412, maintaining a Buy rating following strong quarterly results and increased revenue guidance.

2026. g. 31. jūl. 23:01 UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

Salīdzinājums

Cenas izmaiņa

West Pharmaceutical Services Inc Prognoze

Cenas mērķis

By TipRanks

17.66% augšup

Prognoze 12 mēnešiem

Vidējais 407.375 USD  17.66%

Augstākais 447 USD

Zemākais 365 USD

Pamatojoties uz 9 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi West Pharmaceutical Services Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

9 ratings

8

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

320 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat